Wachtell, Lipton, Rosen & Katz represented LTK in the transaction. Kirkland & Ellis advised Maverick Ventures. Latham & Watkins represented SoftBank Vision Fund 2. LTK (formerly rewardStyle...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented Pfizer in the transaction. Pfizer Inc. (NYSE: PFE) has entered into an agreement with Altaris Capital Partners, LLC, a healthcare...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised SWORD Health on the deal. SWORD Health announced the completion of its $85 million Series C funding round led by General Catalyst. Other participating...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented ArcLight, while Wachtell, Lipton, Rosen & Katz represented PSEG in the transaction. Public Service Enterprise Group Inc. (NYSE: PEG) has entered into an...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Vedanta Biosciences on the deal. Vedanta Biosciences announced the closing of a $68 million Series D financing. The round was led by affiliates of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...
You must be a Standard 1 Year member to access this content.
Dentons represented Weingarten Realty Investors, while Wachtell, Lipton, Rosen & Katz represented Kimco in the transaction. Weingarten Realty Investors, a shopping center owner, manager and developer,...
You must be a Standard 1 Year member to access this content.
